• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡甲胺锑酸盐(葡酸锑钠,商品名Glucantime)治疗泛发性皮肤利什曼病时的肾毒性。

Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis.

作者信息

Rodrigues M L, Costa R S, Souza C S, Foss N T, Roselino A M

机构信息

Division of Dermatology, Faculty of Medicine of Ribeirão Preto, SP, Brazil.

出版信息

Rev Inst Med Trop Sao Paulo. 1999 Jan-Feb;41(1):33-7. doi: 10.1590/s0036-46651999000100007.

DOI:10.1590/s0036-46651999000100007
PMID:10436668
Abstract

BACKGROUND

Pentavalent antimonials have became of basic importance for the treatment of leishmaniasis. Their most severe side effects have been reported to be increased hepatic enzyme levels and electrocardiographic abnormalities. Nephrotoxicity has been rarely related.

OBSERVATIONS

We report a case of generalized cutaneous leishmaniasis involving a 50-year old male patient who was submitted to treatment with meglumine antimoniate (Glucantime). He developed acute renal failure (ARF) due to acute tubular necrosis (ATN), followed by death after receiving a total of 53 ampoules of Glucantime.

CONCLUSIONS

The treatment with Glucantime was responsible by ARF diagnosed in this patient. The previous urine osmolarity and serum creatinine levels were normal and the autopsy showed ATN. It should be pointed out if ARF may also be explained by massive deposits of immunocomplexes by leishmania antibodies and antigens due to the antigenic break by the antimonial compound, since our patient presented countless lesions covering the entire tegument, similar to the Hexheimer phenomenon, but at the autopsy no glomerular alterations were seen.

摘要

背景

五价锑剂已成为治疗利什曼病的重要基础药物。据报道,其最严重的副作用是肝酶水平升高和心电图异常。肾毒性很少见。

观察结果

我们报告一例50岁男性全身性皮肤利什曼病患者,接受葡甲胺锑酸盐(葡糖胺锑)治疗。他因急性肾小管坏死(ATN)发展为急性肾衰竭(ARF),在总共接受53支葡糖胺锑治疗后死亡。

结论

该患者诊断的急性肾衰竭由葡糖胺锑治疗引起。患者之前的尿渗透压和血清肌酐水平正常,尸检显示为急性肾小管坏死。需要指出的是,急性肾衰竭也可能是由于锑化合物导致抗原性破坏,利什曼原虫抗体和抗原形成大量免疫复合物沉积所致,因为我们的患者全身出现无数皮损,类似于赫克斯海默现象,但尸检未发现肾小球改变。

相似文献

1
Nephrotoxicity attributed to meglumine antimoniate (Glucantime) in the treatment of generalized cutaneous leishmaniasis.葡甲胺锑酸盐(葡酸锑钠,商品名Glucantime)治疗泛发性皮肤利什曼病时的肾毒性。
Rev Inst Med Trop Sao Paulo. 1999 Jan-Feb;41(1):33-7. doi: 10.1590/s0036-46651999000100007.
2
[Renal changes caused by pentavalent antimonial (Glucantime) hypersensitivity in American tegumentary leishmaniasis. Report of a case].[美国皮肤利什曼病中五价锑(葡糖胺锑)超敏反应引起的肾脏改变。病例报告]
Rev Inst Med Trop Sao Paulo. 1990 Jul-Aug;32(4):249-51. doi: 10.1590/s0036-46651990000400003.
3
Systemic Meglumine Antimoniate in Cutaneous Leishmaniasis of Children: Clinical and Laboratory Complications.儿童皮肤利什曼病中使用葡甲胺锑酸盐的全身性治疗:临床和实验室并发症
J Pediatric Infect Dis Soc. 2015 Dec;4(4):356-8. doi: 10.1093/jpids/piu021. Epub 2014 Apr 3.
4
First report on ototoxicity of meglumine antimoniate.葡甲胺锑酸盐耳毒性的首次报告。
Rev Inst Med Trop Sao Paulo. 2014 Sep-Oct;56(5):439-42. doi: 10.1590/s0036-46652014000500012.
5
[Cardiotoxicity of n-methyl-glucamine antimoniate (Glucantime). A case report].
Med Mal Infect. 2007 Dec;37 Suppl 3:S257-9. doi: 10.1016/j.medmal.2007.08.001. Epub 2007 Nov 28.
6
[Side effects of meglumine antimoniate in cutaneous leishmaniasis: 15 cases].葡甲胺锑酸盐治疗皮肤利什曼病的副作用:15例报告
Tunis Med. 2010 Jan;88(1):9-11.
7
Adverse effects of intralesional meglumine antimoniate and its influence on clinical laboratory parameters in the treatment of cutaneous leishmaniasis.米诺环素局部注射治疗皮肤利什曼病的不良反应及其对临床实验室参数的影响。
Int J Dermatol. 2012 Oct;51(10):1221-5. doi: 10.1111/j.1365-4632.2012.05460.x.
8
[Glucantime reaction with fatal outcome following treatment of cutaneous leishmaniasis].[皮肤利什曼病治疗后发生致命结局的葡聚糖铁反应]
Ann Dermatol Venereol. 2008 Apr;135(4):317-8. doi: 10.1016/j.annder.2007.10.003. Epub 2008 Mar 20.
9
[Adverse events related to systemic treatment using Glucantime for cutaneous leishmaniasis: a report from Tunisia].[使用葡聚糖铁治疗皮肤利什曼病的全身治疗相关不良事件:突尼斯的一份报告]
Med Trop (Mars). 2008 Oct;68(5):499-501.
10
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.热疗。一种治疗美国皮肤利什曼病的替代方法。
Trials. 2012 May 17;13:58. doi: 10.1186/1745-6215-13-58.

引用本文的文献

1
Cutaneous leishmaniasis in Afghanistan.阿富汗的皮肤利什曼病
Trans R Soc Trop Med Hyg. 2025 Aug 8;119(8):848-864. doi: 10.1093/trstmh/traf028.
2
Epoxy-a-lapachone in nanosystem: a prototype drug for leishmaniasis assessed in the binomial BALB/c - Leishmania (Leishmania) amazonensis.纳米体系中环氧化拉帕醌:用于利什曼病的原型药物,在二项式 BALB/c-利什曼原虫(利什曼原虫)亚马逊亚种中进行评估。
Mem Inst Oswaldo Cruz. 2024 Oct 28;119:e240115. doi: 10.1590/0074-02760240115. eCollection 2024.
3
Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers.
自行使用氨基糖苷类乳膏治疗旅行者皮肤利什曼病。
PLoS Negl Trop Dis. 2023 Aug 10;17(8):e0011492. doi: 10.1371/journal.pntd.0011492. eCollection 2023 Aug.
4
Evaluation of the Efficacy of Amphotericin B and Terbinafine Microemulsions and Their Combination on Cutaneous Leishmaniasis and Comparison with the Conventional Drug Form in BALB/c Mice.评价两性霉素 B 和特比萘芬微乳及其联合用药对皮肤利什曼病的疗效,并与 BALB/c 小鼠中的常规药物剂型进行比较。
AAPS PharmSciTech. 2022 Oct 14;23(7):280. doi: 10.1208/s12249-022-02435-1.
5
Treatment of canine leishmaniasis with marbofloxacin in dogs with renal disease.用马波沙星治疗患有肾脏疾病犬的犬利什曼病
PLoS One. 2017 Oct 5;12(10):e0185981. doi: 10.1371/journal.pone.0185981. eCollection 2017.
6
Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial.冷冻疗法联合外用刺柏乳膏与冷冻疗法联合安慰剂治疗旧大陆皮肤利什曼病的疗效:一项三盲随机对照临床试验。
PLoS Negl Trop Dis. 2017 Oct 5;11(10):e0005957. doi: 10.1371/journal.pntd.0005957. eCollection 2017 Oct.
7
Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis.免疫菌素ImmA和ImmH在实验性内脏利什曼病治疗中有效且无毒。
PLoS Negl Trop Dis. 2015 Dec 23;9(12):e0004297. doi: 10.1371/journal.pntd.0004297. eCollection 2015 Dec.
8
Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.铋(III)α-羟基羧酸盐:乙醇酸盐对硕大利什曼原虫的高度选择性毒性。
J Biol Inorg Chem. 2015 Oct;20(7):1193-203. doi: 10.1007/s00775-015-1299-6. Epub 2015 Sep 28.
9
Renal involvement in leishmaniasis: a review of the literature.利什曼病的肾脏受累:文献综述
NDT Plus. 2011 Jun;4(3):147-52. doi: 10.1093/ndtplus/sfr008. Epub 2011 Mar 21.
10
Kidney involvement in leishmaniasis--a review.利什曼病中的肾脏受累——综述
Braz J Infect Dis. 2014 Jul-Aug;18(4):434-40. doi: 10.1016/j.bjid.2013.11.013. Epub 2014 Mar 29.